Cook Advance CS Coronary Sinus Infusion Catheter

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Available from:

COOK SOUTH EAST ASIA PTE LTD

Class:

Class D medical device

Manufactured by:

Cook Incorporated

Therapeutic area:

Cardiovascular

Therapeutic indications:

The Advance CS Coronary Sinus Infusion Catheter is intended for temporary occlusion of the coronary sinus for infusion of contrast media, drugs, or therapeutic agents; or for possible introduction of devices in to the coronary venous system.

Product summary:

Device System Info:[Sterile Medical Device], Sterilized Ethylene Oxide; Models: Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-80-5-4.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-80-5-2.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-135-9-4.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-80-6-2.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-80-6-4.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-80-7-2.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-80-7-4.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-80-8-3.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-80-8-4.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-80-9-3.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-80-9-4.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-135-5-2.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-135-5-4.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-135-6-2.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-135-6-4.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-135-7-2.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-135-7-4.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-135-8-3.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-135-8-4.0-RCSI, Advance® CS Coronary Sinus Infusion Catheter - PTA5-35-135-9-3.0-RCSI

Authorization date:

2017-07-20